In a recent social media post, Marjorie Taylor Greene criticized the Food and Drug Administration after the agency approved a ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

From eligibility to dosage and future rollout, here’s what you need to know about the FDA’s latest vaccine approval.

Moderna said mNEXSPIKE was approved by the FDA for use in adults aged 65 and up, as well as some individuals aged 12 to 64.

FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...

Moderna has withdrawn the BLA for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after consulting with FDA.

The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...

Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...

Practices can delabel other suspected drug allergies while assessing patients for allergies to COVID-19 vaccines, according to a study published in Vaccine. This program can improve health-related ...

A new, highly transmissible COVID subvariant has been detected in California—heightening the risk of a potential summer wave ...

Jefferies analysts said the approval was largely expected and an “incremental positive” for Moderna amid questions about the ...

U.S. steel stocks, more. Wall Street sees more weakness ahead for U.S. dollar. Indivior to delist from London Stock Exchange, ...